Bristol-Myers Squibb (BMY) Stock Statistics & Valuation Metrics

Bristol-Myers Squibb has a market cap or net worth of $121.64B. The enterprise value is $160.50B.

Bristol-Myers Squibb has 2,036,473,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Bristol-Myers Squibb’s return on equity (ROE) is 0.38 and return on invested capital (ROIC) is 13.90%.

The current PE Ratio of Bristol-Myers Squibb is 17.3. Bristol-Myers Squibb’s PEG ratio is -0.09.

In the last 12 months, Bristol-Myers Squibb had revenue of 48.19B and earned 7.05B in profits. Earnings per share was 3.46.

In the last 12 months, operating cash flow was 14.16B and capital expenditures -1.31B, giving a free cash flow of 12.85B billion.

Bristol-Myers Squibb pays an annual dividend of $0.62, resulting in a dividend yield of 4.84%

Bristol-Myers Squibb upcoming earnings date is Apr 30, 2026, Before Open (Confirmed).

Bristol-Myers Squibb as a current ratio of 1.26, with Debt / Equity ratio of 255.18%

In the past 12 months, Bristol-Myers Squibb has paid 2.27B in taxes.

Bristol-Myers Squibb EV to EBITDA ratio is 10.11, with an EV/FCF ratio of 11.45.

Bristol-Myers Squibb has $10.67B in cash and marketable securities with $47.14B in debt, giving a net cash position of -$36.47B billion.

Gross margin is 67.65%, with operating margin of 26.34%, and net profit margin of 14.63%.

The average price target for Bristol-Myers Squibb is $60.68, which is 11.43% higher than the current price. The consensus rating is Moderate Buy